Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04427787 |
|---|---|
| Brief Title: | A Trial Aiming to Assess the Safety and Activity of the Combination of Cabozantinib Plus Lanreotide in GEP and NET (LOLA) |
| First Submitted : | June 9, 2020 |
| First Submitted that Met QC Criteria : | June 9, 2020 |
| First Posted : | June 11, 2020 |
| Last Update Submitted that Met QC Criteria : | July 2, 2020 |
| Last Update Posted : | July 7, 2020 |